Basics Senseonics Holdings, Inc. Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients. IPO Date: February 22, 2000 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $399.7M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 3.89% Avg Daily Range (30 D): $0.02 | 3.01% Avg Daily Range (90 D): $0.04 | 4.42% Institutional Daily Volume Avg Daily Volume: 5.3M Avg Daily Volume (30 D): 5.18M Avg Daily Volume (90 D): 5.96M Trade Size Avg Trade Size (Sh.): 453 Avg Trade Size (Sh.) (30 D): 569 Avg Trade Size (Sh.) (90 D): 602 Institutional Trades Total Inst.Trades: 444 Avg Inst. Trade: $2.06M Avg Inst. Trade (30 D): $2.32M Avg Inst. Trade (90 D): $3.34M Avg Inst. Trade Volume: 1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.45M Avg Closing Trade (30 D): $2.32M Avg Closing Trade (90 D): $3.91M Avg Closing Volume: 1.78M     News May 21, 2025 @ 9:06 PM Senseonics Holdings, Inc. Announces Closing of Pub... Source: N/A May 21, 2025 @ 5:47 PM Diabetic Care Device Market Set for Significant Gr... Source: Bcc Research Jan 8, 2025 @ 11:12 PM Senseonics Holdings, Inc. Announces Business Updat... Source: N/A Sep 17, 2024 @ 11:00 AM Eversense 365 Receives FDA Clearance: The Worldââ... Source: Senseonics Holdings, Inc. And Ascensia Diabetes Care Jul 23, 2024 @ 5:31 PM [Latest] US Diabetes Devices Market Size/Share Wor... Source: Custom Market Insights Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.11 $-.02 $-.02 Diluted EPS $-.11 $-.02 $-.02 Revenue $ 23.68M $ 6.26M $ 8.3M Gross Profit $ 1.7M $ 1.51M $ 3.95M Net Income / Loss $ -74M $ -14.26M $ -15.48M Operating Income / Loss $ -70.1M $ -13.49M $ -14.27M Cost of Revenue $ 21.98M $ 4.75M $ 4.35M Net Cash Flow $ -51.23M $ -35.29M $ 47.49M PE Ratio     Splits Nov 10, 2015:   12:1